![]() |
OTCQB PodcastAuthor: OTC Markets Group
OTC Markets presents our podcast series on the OTCQB Market, where we interview the entrepreneurs behind the companies that trade on the venture market. Language: en Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Neurizon Therapeutics LTD.
Episode 4
Monday, 9 February, 2026
Neurizon Therapeutics LTD. (OTCQB: NUZTF) is an Australian clinical-stage biotech company focused on developing treatments for neurodegenerative diseases, with their lead program aimed at ALS. Michael Thurn, CEO and Managing Director of Neurizon, joins us to discuss their mission to address neurodegenerative diseases through its lead ALS therapy View Podcast Transcript













